Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
POLYCYCLIC COMPOUND AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/217156
Kind Code:
A1
Abstract:
A polycyclic compound, a preparation method therefor, and the use thereof in the prevention and/or treatment of proliferative diseases. The compound has a structure as represented by formula (I):

Inventors:
LIANG APENG (CN)
LIU GUANGBIN (CN)
CHEN SHAOQING (CN)
LI JUN (CN)
WU YUSHENG (CN)
YIN ZHOU (CN)
DONG SHENGLI (CN)
NIU CHENGSHAN (CN)
LI MEIHUA (CN)
Application Number:
PCT/CN2023/093095
Publication Date:
November 16, 2023
Filing Date:
May 09, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
TYK MEDICINES INC (CN)
International Classes:
C07D401/04; A61K31/44; A61P35/00; C07D401/14
Domestic Patent References:
WO2018014880A12018-01-25
WO2009081259A12009-07-02
WO2010077992A12010-07-08
WO2019222538A12019-11-21
WO2019089626A12019-05-09
Foreign References:
CN102300860A2011-12-28
CN103814016A2014-05-21
CN102250022A2011-11-23
Other References:
TALMON MARIA ET AL.: "Design, Synthesis and Biological Evaluation of Vortioxetine Derivatives as New COX-1/2 Inhibitors in Human Monocytes", BIOORGANIC & MEDICINAL CHEMISTRY, vol. 28, no. 23, 11 September 2020 (2020-09-11), XP086403194, ISSN: 1464-3391, DOI: 10.1016/j.bmc.2020.115760
DATABASE REGISTRY 14 September 2017 (2017-09-14), ANONYMOUS: "2-Buten-1-one, 4-(dimethylamino)-1-[4-[3-[(3-methyl-2-pyridinyl)amino]-2- pyrazinyl]-1-piperidinyl]- (CA INDEX NAME)", XP093108525, retrieved from STNext Database accession no. 2127383-47-3
Attorney, Agent or Firm:
XU & PARTNERS, LLC. (CN)
Download PDF: